These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

16 related articles for article (PubMed ID: 3780812)

  • 1. Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients.
    Larsson R; Dhar S; Ehrsson H; Nygren P; Lewensohn R
    Br J Cancer; 1998 Aug; 78(3):328-35. PubMed ID: 9703278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of peptide bound m-L-sarcolysin (peptichemio) on melphalan resistant human myeloma cells in vitro.
    Lewensohn R; Fernberg JO; Ehrsson H; Merlini G
    Med Oncol Tumor Pharmacother; 1991; 8(4):265-9. PubMed ID: 1820493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptichemio in pretreated patients with ovarian cancer.
    Paccagnella A; Tredese F; Salvagno L; Brandes A; Sileni VC; Daniele O; Fornasiero A; Fosser V; Nicoletto O; Maggino T
    Cancer Treat Rep; 1985 Jan; 69(1):17-20. PubMed ID: 3155650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptichemio induction therapy in myelomatosis.
    Merlini G; Gobbi PG; Riccardi A; Riva G; Sardi C; Perugini S
    Cancer Chemother Pharmacol; 1982; 8(1):9-16. PubMed ID: 7094202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptichemio in advanced breast cancer: a clinical evaluation in 32 patients.
    Fornasiero A; Daniele O; Fosser VP; Paccagnella A; Salvagno L; Sileni VC; Morandi P; Fiorentino MV
    Cancer Treat Rep; 1986 May; 70(5):647-9. PubMed ID: 3708613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptichemio in multiple myeloma. (Preliminary results).
    Cavo M; Gobbi M; Tura S
    Haematologica; 1981 Apr; 66(2):208-15. PubMed ID: 6791997
    [No Abstract]   [Full Text] [Related]  

  • 7. Peptichemio versus melphalan (L-PAM) in advanced breast cancer.
    Buzdar AU; Legha SS; Blumenschein GR; Hortobagyi GN; Yap HY; Schell FC; Barnes BC; Fraschini G; Bodey GP
    Cancer; 1982 May; 49(9):1767-70. PubMed ID: 7042074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptichemio in pretreated patients with plasmacell neoplasms.
    Paccagnella A; Salvagno L; Chiarion-Sileni V; Bolzonella S; De Besi P; Frizzarin M; Pappagallo GL; Fosser VP; Fornasiero A; Segati R
    Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1053-8. PubMed ID: 3780812
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.